PeptAIDes

Roland Hellinger contributed to a peer review publication in the Journal of Biomedicine & Pharmacotherapy.

The study with the title ‚The nature inspired peptide [T20K]-kalata B1 induces anti-tumor effects in anaplastic large cell lymphoma‘ studied the effects of T20K. The collaborative work was performed by researchers from the Medical University of Vienna, the Ludwig Boltzmann Institute for Cancer Research, the Karl Landsteiner University of Health Sciences, and the University of Veterinary Medicine in Vienna.

Here is a link to the online version of the article. Link